Cutler Group LP Madrigal Pharmaceuticals, Inc. Transaction History

Cutler Group LP

$307 Million
Q1 2024

A detailed history of Cutler Group LP transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Cutler Group LP holds 15,800 shares of MDGL stock, worth $4.93 Million. This represents 1.37% of its overall portfolio holdings.

Number of Shares

15,800

Previous 13,500 17.04%

Holding current value

$4.93 Million

Previous $3.12 Million 35.09%

% of portfolio

1.37%

Previous 0.28%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	BUY	$171.37 - $283.23 $394,151 - $651,429	2,300 Added 17.04%	15,800 $4.22 Million
Q4 2023 Jan 18, 2024	BUY	$120.4 - $237.13 $385,280 - $758,816	3,200 Added 31.07%	13,500 $3.12 Million
Q3 2023 Nov 07, 2023	BUY	$146.04 - $225.78 $496,536 - $767,652	3,400 Added 49.28%	10,300 $1.5 Million
Q2 2023 Jul 18, 2023	BUY	$203.88 - $312.0 $570,864 - $873,600	2,800 Added 68.29%	6,900 $1.59 Million
Q1 2023 May 01, 2023	BUY	$231.06 - $307.08 $947,346 - $1.26 Million	4,100 New	4,100 $993,000
Q3 2022 Oct 25, 2022	SELL	$60.57 - $79.51 $149,305 - $195,992	-2,465 Reduced 98.01%	50 $3,000
Q2 2022 Aug 04, 2022	SELL	$58.04 - $100.2 $32,618 - $56,312	-562 Reduced 18.26%	2,515 $180,000
Q1 2022 Apr 14, 2022	BUY	$55.89 - $101.89 $84,226 - $153,548	1,507 Added 95.99%	3,077 $301,000
Q4 2021 Jan 18, 2022	SELL	$72.34 - $95.09 $16,638 - $21,870	-230 Reduced 12.78%	1,570 $133,000
Q3 2021 Oct 26, 2021	BUY	$78.35 - $105.02 $20,371 - $27,305	260 Added 16.88%	1,800 $143,000
Q2 2021 Jul 19, 2021	BUY	$97.2 - $137.59 $62,208 - $88,057	640 Added 71.11%	1,540 $150,000
Q1 2021 Apr 26, 2021	BUY	$108.54 - $125.2 $75,978 - $87,640	700 Added 350.0%	900 $105,000
Q4 2020 Jan 21, 2021	SELL	$110.06 - $133.7 $330,180 - $401,099	-3,000 Reduced 93.75%	200 $22,000
Q3 2020 Oct 27, 2020	BUY	$99.78 - $124.21 $201,356 - $250,655	2,018 Added 170.73%	3,200 $379,000
Q2 2020 Jul 22, 2020	SELL	$60.13 - $125.71 $19,121 - $39,975	-318 Reduced 21.2%	1,182 $133,000
Q1 2020 May 07, 2020	BUY	$66.76 - $93.49 $6,342 - $8,881	95 Added 6.76%	1,500 $100,000
Q4 2019 Feb 06, 2020	SELL	$84.28 - $118.5 $25,284 - $35,550	-300 Reduced 17.6%	1,405 $128,000
Q3 2019 Oct 28, 2019	BUY	$84.4 - $106.53 $98,072 - $123,787	1,162 Added 214.0%	1,705 $147,000
Q2 2019 Aug 09, 2019	SELL	$91.13 - $142.5 $269,289 - $421,087	-2,955 Reduced 84.48%	543 $56,000
Q1 2019 May 10, 2019	BUY	$103.48 - $143.84 $86,095 - $119,674	832 Added 31.21%	3,498 $438,000
Q3 2018 Nov 07, 2018	BUY	$207.3 - $300.31 $345,361 - $500,316	1,666 Added 166.6%	2,666 $570,000
Q2 2018 Aug 10, 2018	BUY	$101.55 - $313.9 $101,550 - $313,900	1,000 New	1,000 $279,000

Others Institutions Holding MDGL

# of Institutions

297

Shares Held

22M

Call Options Held

819K

Put Options Held

640K

View Full List

About MADRIGAL PHARMACEUTICALS, INC.

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.34B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

More about MDGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account